There were also studies which demonstrated that breast cancer patients with HER2 type tumor (ER/PR−, HER2+) and basal type tumor (triple negative, ER/PR−, HER2−) displayed increased risk for local recurrence30–32. This evidence concerns the gene PGR and breast carcinoma.